De-Novo Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Following the mRNA-1273 (Moderna) Vaccine for COVID-19
| Autor: | Sidrah Abid, Elio Junior Feghali, Dominick Santoriello, Swati Mehta, Maha Zafar |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Messenger RNA
Coronavirus disease 2019 (COVID-19) business.industry General Engineering urologic and male genital diseases mrna-1273 vaccine medicine.disease Rheumatology acute kidney injury Nephrology Immunology Pathology Medicine cardiovascular diseases pr3-anca business Vasculitis glomerulonephritis coronavirus disease (covid-19) Anti-neutrophil cytoplasmic antibody |
| Zdroj: | Cureus |
| ISSN: | 2168-8184 |
| DOI: | 10.7759/cureus.19616 |
| Popis: | Antineutrophil cytoplasmic antibody (ANCA) is a systemic autoimmune disorder characterized by antibodies directed against small- and moderate-sized vessels. While there are few reported cases of autoimmune illnesses associated with influenza vaccination, two cases of de-novo anti-proteinase (PR3) ANCA-associated pauci immune glomerulonephritis are reported after the mRNA-1273 coronavirus disease 2019 (COVID-19) vaccine. Here, we report the third case of ANCA-associated glomerulonephritis after the mRNA-1273 COVID-19 vaccine. Our patient presented with acute kidney injury and sub-nephrotic proteinuria four days after receiving the second dose of the COVID vaccine. He was found to have elevated c-ANCA and anti-PR3 antibodies. Renal biopsy confirmed focal necrotizing and diffuse crescentic glomerulonephritis. He was diagnosed with pauci immune glomerulonephritis. The patient achieved remission 10 weeks after the diagnosis with successful treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|